Monash Quality of Medicines Initiative receives grant as part of collaboration to investigate climate resilience of critical medicines

6 August 2026

This project aims to safeguard access to effective medicines despite rising extreme heat from climate change. It builds capability to deliver guidance from bench to policy by identifying heat-vulnerable drugs in regions with vulnerable supply chains in the Western Pacific, and synthesis evidence on heat stability for adrenaline. This supports priority-setting for manufacturers and policy makers; reduces medicine waste; informs future formulation improvements; and identifies targets for future research.